AstraZeneca, Roche to boost digital pathology uptake in APAC and more briefs

Also, SoftBank, SMBC, and Fujitsu have announced a partnership to develop a new health data platform and AI agent-based personalised health app. AstraZeneca and Roche Diagnostics Asia Pacific have signed a three-year memorandum of understanding to promote AI-powered digital pathology and biomarker testing for breast and lung cancer across nine Asian markets. According to a press release, the collaboration will support education and training initiatives in Singapore, Taiwan, Korea, Thailand, Malaysia, India, Indonesia, Vietnam and the Philippines to accelerate AI-assisted digital pathology adoption and improve biomarker testing, including HER2 assessment in breast cancer and TROP2 assessment in non-small cell lung…

Source: Healthcare IT News